1579 Results

People

  1. Cheung
    Cheung
  2. Wolchok
    Wolchok
  3. Postow
    Postow
  4. Hellmann
    Hellmann
  5. Adusumilli
    Adusumilli
  6. Old
    Old
  7. Livingston
    Livingston
  8. Motzer
    Motzer
  9. Slovin
    Slovin
  10. Houghton
    Houghton

Groups

  1. Department of Medicine (882)
  2. Solid Tumor Oncology Division (646)
  3. GSK Faculty (409)
  4. Hematologic Malignancies, Division of (373)
  5. Sloan Kettering Institute Postdocs (252)
  6. Melanoma and Immunotherapeutics Service (227)
  7. Center for Hematologic Malignancies (221)
  8. Surgery (221)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (191)
  10. Melanoma Disease Management Team (186)
  1. "immunotherapy"
Formats
  1. Journal Article (1126)
  2. Review (243)
  3. Editorial (60)
  4. Meeting Abstract (57)
  5. Book Section (30)
  6. Guidelines (28)
  7. Research Letter (14)
  8. Conference Paper (9)
  9. Correspondence (7)
  10. Miscellaneous (5)
Groups
  1. Department of Medicine (882)
  2. Solid Tumor Oncology Division (646)
  3. GSK Faculty (409)
  4. Hematologic Malignancies, Division of (373)
  5. Sloan Kettering Institute Postdocs (252)
  6. Melanoma and Immunotherapeutics Service (227)

More Groups

People
  1. Jedd Wolchok (107)
  2. Nai-Kong Cheung (71)
  3. Michael Postow (67)
  4. Matthew Hellmann (53)
  5. Prasad Adusumilli (39)
  6. Michel Sadelain (36)

More People

Years
  1. 2025 (69)
  2. 2024 (160)
  3. 2023 (135)
  4. 2022 (134)
  5. 2021 (129)
  6. 2020 (102)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (117)
  2. Journal of Thoracic Oncology (55)
  3. Clinical Cancer Research (41)
  4. Annals of Oncology (35)
  5. Cancer Immunology, Immunotherapy (29)
  6. Cancer (28)

More Publications

Publishers
  1. Elsevier Inc. (242)
  2. Biomed Central Ltd (139)
  3. Springer (103)
  4. Wiley Blackwell (83)
  5. American Association for Cancer Research (69)
  6. Oxford University Press (67)

More Publishers

Results (1579)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The weighted toxicity score: Confirmation of a simple metric to communicate toxicity in randomized trials of systemic cancer therapy
    Journal Article

    Jordan, J.; Maki, R. G.
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Immune effects of intra-arterial liver-directed therapies
    Review

    Karimi, A.; Yarmohammadi, H.; Erinjeri, J. P.
    Journal of Vascular and Interventional Radiology (2024)

    Fulltext@MSK | Save
  • Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: Results from Study 111/KEYNOTE-146
    Journal Article

    Makker, V.; Taylor, M. H.; Aghajanian, C.; Cohn, A. L.; Brose, M. S.; Simone, C. D.; Cao, Z. A.; Suttner, L.; Loboda, A.; Cristescu, R.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Xaluritamig, a STEAP1 × CD3 XmAb 2+1 immune therapy for metastatic castration-resistant prostate cancer: Results from dose exploration in a first-in-human study
    Journal Article

    Kelly, W. K.; Danila, D. C.; Lin, C. C.; Lee, J. L.; Matsubara, N.; Ward, P. J.; Armstrong, A. J.; Pook, D.; Kim, M.; Dorff, T. B.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Melanoma and microbiota: Current understanding and future directions
    Review

    Routy, B.; Jackson, T.; Mählmann, L.; Baumgartner, C. K.; Blaser, M.; Byrd, A.; Corvaia, N.; Couts, K.; Davar, D.; Derosa, L.; more...
    Cancer Cell (2024)

    Fulltext@MSK | Save
  • Early-stage triple-negative breast cancer
    Book Section

    Traina, T. A.; dos Anjos, C.; Walsh, E.
    In Abutalib, S. A.; Markman, M.; Benson, A. B. 3rd; Rugo, H. S. (Eds.) Cancer Consult: Expertise in Clinical Practice (2024)

    Fulltext@MSK | Save
  • Cardiac radiation dose is associated with inferior survival but not cardiac events in patients with locally advanced non-small cell lung cancer in the era of immune checkpoint inhibitor consolidation
    Journal Article

    Yegya-Raman, N.; Ho Lee, S.; Friedes, C.; Wang, X.; Iocolano, M.; Kegelman, T. P.; Duan, L.; Li, B.; Berlin, E.; Kim, K. N.; more...
    Radiotherapy and Oncology (2024)

    Fulltext@MSK | Save
  • The features and management of acquired resistance to PD1-based therapy in metastatic melanoma
    Journal Article

    Hepner, A.; Versluis, J. M.; Wallace, R.; Allayous, C.; Brown, L. J.; Trojaniello, C.; Gerard, C. L.; Jansen, Y. J. L.; Bhave, P.; Neyns, B.; more...
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Results of a phase Ib study investigating durvalumab in combination with eribulin in patients with HER2-negative metastatic breast cancer and recurrent ovarian cancer
    Journal Article

    Landry, C. A.; Blanter, J.; Ru, M.; Fasano, J.; Klein, P.; Shao, T.; Bhardwaj, A.; Tiersten, A.
    Oncology (2024)

    Fulltext@MSK | Save
  • Nivolumab and daratumumab combination regimens for the treatment of relapsed and refractory multiple myeloma: Results of a randomized phase I/II clinical trial
    Journal Article

    Abdallah, A. O.; Lesokhin, A.; Wrobel, T.; Jamroziak, K.; Dytfeld, D.; Touzeau, C.; Suvannasankha, A.; Leleu, X.; Silbermann, R.; Khan, A. M.; more...
    Frontiers in Hematology (2023)

    Fulltext@MSK | Save